Does Preoperative MIBI Scanning Lead to Improved Outcomes in Patients Undergoing Abdominal Aortic Aneurysm Surgery?

Abstract

Dipyridamole sestamibi nuclear scanning (MIBI) is a commonly used test to screen for cardiac disease in patients undergoing elective abdominal aortic aneurysm (AAA) surgery. However, its routine use for all patients is controversial. The purpose of this study was to determine whether MIBI scanning could identify high-risk patients and lead to decreased myocardial infarction (MI) and cardiac death when compared with patients who did not receive MIBI scanning preoperatively. The authors reviewed 212 consecutive patients undergoing elective AAA repair between January 1990 and December 1993. Data regarding preoperative cardiac status, MIBI scan results, and cardiovascular outcomes were collected. During this period, 92 patients had MIBI scans preoperatively while 120 patients underwent AAA surgery without MIBI scanning. The average ages for these two groups were 70 ±8 and 71 ±9 years, respectively. The frequency of coronary artery disease, angina, and previous MI in the MIBI group was 47%, 26%, and 29%, respectively. In the non-MIBI group, these frequencies were 39%, 23%, and 28%, respectively. Eleven patients were identified in the MIBI group to have moderate or large reversible defects. Of these, five underwent cardiac revascularization with no morbidity. The frequency of postoperative MI and death for the MIBI group was 1.1% (1/92) and 0%, respectively. In the non-MIBI group, it was 3.3% (4/120) and 1.7% (2/120), respectively (p=0.54). Preoperative MIBI scanning identified high-risk patients for AAA surgery. Following coronary revascularization for these high-risk patients, the overall MI and mortality rates were similar to those in patients who did not receive MIBI preoperatively.

Get full access to this article

View all access options for this article.

References

1. Johnston KW : Multicenter prospective study of nonruptured abdominal aortic aneurysm. Part II. Variables predicting morbidity and mortality. J Vasc Surg 9:437-447, 1989.

2. Goldman L : Assessment of perioperative cardiac risk. N Engl J Med 330:707-709, 1994.

3. Boucher CA , Brewster DC , Darling RC , et al: Determination of cardiac risk by dipyridamole-thallium imaging before peripheral vascular surgery. N Engl J Med 312:389-394, 1985.

4. Cutler BS , Leppo JA : Dipyridamole thallium 201 scintigraphy to detect coronary artery disease before abdominal aortic surgery. J Vasc Surg 5:91-100, 1987.

5. Sachs RN , Tellier P , Larmignat P , et al: Assessment by dipyridamole thallium 201 myocardial scintigraphy of coronary risk before peripheral vascular surgery. Surgery 103:584-587, 1988.

6. Lane SE , Lewis SM , Pippin JJ , et al: Predictive value of quantitative dipyridamole-thallium scintigraphy in assessing cardiovascular risk after vascular surgery in diabetes mellitus. Am J Cadiol 64:1275-1279, 1989.

7. Lette J , Waters D , Lassonde J , et al: Multivariate clinical models and quantitative dipyridamole thallium imaging to predict cardiac morbidity and death after vascular reconstruction. J Vasc Surg 14:160-169, 1991.

8. Fletcher JP , Antico VF , Gruenewald S , et al: Dipyridamole thallium scan for screening coronary artery disease prior to vascular surgery. J Cardiovasc Surg 29:666-669, 1988.

9. Makaroun MS , Shuman-Jackson N . Rippey A , et al: Cardiac risk in vascular surgery: The oral dipyridamole thallium stress test. Arch Surg 125:1610-1613, 1990.

10.

10. Brown KA , Rowen M : Extent of jeopardized viable myocardium determined by myocardial perfusion imaging best predicts perioperative cardiac events in patients undergoing noncardiac surgery. J Am Coll Cardiol 21:325-330, 1993.

11.

11. Eagle KA , Coley CM , Newell JB , et al: Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med 110:859-866, 1989.

12.

12. Mangano DT , London MJ , Tubau JF , et al: Dipyridamole thallium 201 scinitigraphy as a preoperative screening test. A reexamination of its predictive potential. Circulation 84:493-502, 1991.

13.

13. Baron JF , Mundler O , Bertrand M , et al: Dipyridamole thallium scinitigraphy and gated radionuclide angiography to assess cardiac risk before abdominal aortic surgery. N Engl J Med 330 :663-669,1994.